Shandong Weigao Group Medical Polymer Company Stock Forecast for 2023 - 2025 - 2030
Updated on 05/01/2024
Shandong Weigao Group Medical Polymer Company Stock Forecast and Price Target
Year-long price target forecasts from two prominent analysts have recently been released for Shandong Weigao Group Medical Polymer Company, with an average price target of HK$7.12. This potential gain of 33.33 percent from the previous closing price in April, 2024 is calculated on a high forecast of HK$8.02 and a low estimate of HK$5.91. Even if you are not interested in 1066 stock, you should be aware of its competitors and their current standings.
33.33% Upside
Shandong Weigao Group Medical Polymer Company Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Shandong Weigao Group Medical Polymer Company's Price has decreased from HK$7.68 to HK$0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach HK$11.10 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
A005930 Stock Forecast | Samsung Electronics | Outperform |
10
|
₩77.50k | Buy/Sell | ₩92.49k | 29.03% |
JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$144.59 | Buy/Sell | $174.55 | 17.57% |
AMGN Stock Forecast | Amgen | Outperform |
4
|
$273.94 | Buy/Sell | $303.65 | 16.63% |
ISRG Stock Forecast | Intuitive Surgical | Outperform |
13
|
$370.62 | Buy/Sell | $408.45 | 16.02% |
SYK Stock Forecast | Stryker Corp | Outperform |
10
|
$336.50 | Buy/Sell | $353.16 | 9.51% |
Shandong Weigao Group Medical Polymer Company Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Shandong Weigao Group Medical Polymer Company's Revenue has grown, rising from HK$11.35B to HK$13.62B – a growth of 20.04%. In the next year, analysts believe that Revenue will reach HK$15.76B – an increase of 15.70%. For the next seven years, the forecast is for Revenue to grow by 17.90%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
SAN Stock Forecast | Sanofi | Outperform |
16
|
93.08€ | Buy/Sell | 102.80€ | 17.10% |
BSX Stock Forecast | Boston Scientific | Buy |
11
|
$71.87 | Buy/Sell | $70.14 | 14.09% |
MDT Stock Forecast | Medtronic | Outperform |
11
|
$80.24 | Buy/Sell | $92.47 | 19.02% |
Shandong Weigao Group Medical Polymer Company Dividend per Share Forecast for 2023 - 2025 - 2030
Shandong Weigao Group Medical Polymer Company's Dividend per Share has grown In the last two years, rising from HK$0.13 to HK$0.17 – a growth of 30.77%. In the following year, the 7 analysts surveyed believe that Shandong Weigao Group Medical Polymer Company's Dividend per Share will decrease by 17.65%, reaching HK$0.14. For the next seven years, experts predict that Shandong Weigao Group Medical Polymer Company's Dividend per Share will grow at a rate of 0.88%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
ZBH Stock Forecast | Zimmer Biomet Holdings | Hold |
15
|
$120.28 | Buy/Sell | $132.52 | 13.07% |
4543 Stock Forecast | Terumo | Outperform |
18
|
¥5.63k | Buy/Sell | ¥4.97k | -9.46% |
BAX Stock Forecast | Baxter International Inc | Outperform |
17
|
$40.37 | Buy/Sell | $44.86 | 11.47% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
A028260 Stock Forecast | Samsung C&T | Outperform |
18
|
₩150.10k | Buy/Sell | ₩157.27k | 21.59% |
7733 Stock Forecast | Olympus | Outperform |
18
|
¥2.20k | Buy/Sell | ¥2.30k | 9.07% |
FME Stock Forecast | Fresenius Medical Care AG & Co... | Hold |
18
|
39.60€ | Buy/Sell | 41.13€ | -2.78% |
Shandong Weigao Group Medical Polymer Company EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Shandong Weigao Group Medical Polymer Company's EBITDA has grown by 24.58%, rising from HK$3.00B to HK$3.74B. For the next year, analysts predict that EBITDA will reach HK$4.24B – an increase of 13.36%. Over the next seven years, experts believe that Shandong Weigao Group Medical Polymer Company's EBITDA will grow at a rate of 10.80%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
SN. Stock Forecast | Smith & Nephew | Outperform |
18
|
£9.79 | Buy/Sell | £16.09 | 67.62% |
TFX Stock Forecast | Teleflex Inc | Hold |
13
|
$208.75 | Buy/Sell | $263.46 | 26.95% |
PEN Stock Forecast | Penumbra | Outperform |
9
|
$196.47 | Buy/Sell | $258.62 | 46.10% |
Shandong Weigao Group Medical Polymer Company EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Shandong Weigao Group Medical Polymer Company's EBIT has grown, moving from HK$2.33B to HK$2.98B – an increase of 27.55%. In the next year, analysts predict that EBIT will jump to HK$3.52B – up 18.14% from the current level. Looking ahead to seven years, experts forecast that EBIT will grow by 12.92%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
3402 Stock Forecast | Toray Industries | Outperform |
18
|
¥693.90 | Buy/Sell | ¥891.82 | 34.03% |
NARI Stock Forecast | Inari Medical | Outperform |
14
|
$37.34 | Buy/Sell | $82.67 | 87.47% |
853 Stock Forecast | MicroPort Scientific | Outperform |
6
|
HK$6.29 | Buy/Sell | HK$2.15 | -80.76% |
Shandong Weigao Group Medical Polymer Company EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Shandong Weigao Group Medical Polymer Company's EPS has decreased from HK$0.45 to HK$0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach HK$0.65 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
8086 Stock Forecast | Nipro | Hold |
11
|
¥1.19k | Buy/Sell | ¥0.00 | -7.64% |
1858 Stock Forecast | Beijing Chunlizhengda Medical ... | Buy |
18
|
HK$11.60 | Buy/Sell | HK$20.73 | 83.36% |
1789 Stock Forecast | AK Medical Holdings | Buy |
18
|
HK$5.88 | Buy/Sell | HK$8.31 | 31.29% |